IFP Advisors’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
IFP Advisors's LAB Position: Q3 2026 in Review
IFP Advisors reduced its Standard BioTools (LAB) stake by 90% in Q3 2026, selling an estimated $943 and leaving 142 shares worth $105. The position accounts for ﹤0.01% of the portfolio, ranked #4974.
IFP Advisors first reported a position in LAB in Q1 2022 and has held it in 11 quarters since. The position peaked at $14K in Q2 2022. 3 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- IFP Advisors held 142 shares of Standard BioTools worth $105 as of Q3 2026.
- IFP Advisors sold 1,227 Standard BioTools shares in Q3 2026, an estimated $943.
- Standard BioTools made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4974 holding.
- IFP Advisors first reported a position in Standard BioTools in Q1 2022 and has held it in 11 quarters since.
- IFP Advisors's Standard BioTools position peaked at $14K in Q2 2022.
- 3 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.